● Resources ● Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study.
Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study.
Important notice regarding use of cookies: Our Privacy Policy reflects our use of cookies to collect and process data. By continuing to use this website, you agree to use our cookies and similar technologies as described in our Privacy Policy.